PriceSmart, Inc. (PSMT)

FORM 8-K/A | Amended Current report
Mar. 7, 2019 4:12 PM
|
About: PriceSmart, Inc. (PSMT)View as PDF
PRICESMART INC (Form: 8-K/A, Received: 03/07/2019 16:29:32)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION



Washington, D.C. 20549



Amendment No. 1

to

FORM 8-K



CURRENT REPORT



Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934



Date of Report (Date of earliest event reported): January 30 , 201 9



PriceSmart,   Inc.

(Exact name of registrant as specified in its charter)





 

 

 

 



Delaware

000-22793

33-0628530

 



(State or Other Jurisdiction of

Incorporation)

(Commission File Number)

(I.R.S. Employer

Identification No.)

 



9740 Scranton Road, San Diego, CA 92121

(Address of Principal Executive Offices, including Zip Code)



Registrant's telephone number, including area code: (858) 404-8800



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):



 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2)(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))





Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company   

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.      



 


 

This Amendment No. 1 to Current Report on Form 8-K amends and supplements Item 5.02 to the Current Report on Form 8-K filed by PriceSmart, Inc. (the “Company”) on January 31, 2019.



Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.



As previously reported, on January 30, 2019, the Board of Directors of the Company appointed Sherry S. Bahrambeygui as the Company’s Chief Executive Officer.  Ms. Bahrambeygui had held that position in an interim role since November 16, 2018.  On March 4, 2019, the Company and Ms. Bahrambeygui entered into a new Employment Agreement, which supersedes the Employment Agreement between the Company and Ms. Bahrambeygui dated November 20, 2018 relating to Ms. Bahrambeygui’s service as Interim Chief Executive Officer.



The new Employment Agreement provides for a term expiring August 31, 2020, which will be automatically renewed annually for additional one-year terms, unless either the Company or Ms. Bahrambeygui provides at least 60 days’ notice that the Company or Ms. Bahrambeygui, as the case may be, wishes to terminate the agreement.  The Company may terminate Ms. Bahrambeygui’s employment with cause upon immediate notice or without cause upon 30 days’ prior written notice, or immediately upon Ms. Bahrambeygui’s death or disability.  Ms. Bahrambeygui may terminate her employment without “good reason” on 60 days’ prior written notice or with “good reason” upon 30 days’ notice and opportunity for the Company to cure the conditions providing “good reason.”



The Employment Agreement specifies a base salary of $1,000,000 per year, which may be increased, but not decreased, at the Company’s discretion.  Ms. Bahrambeygui also is entitled to a $27,960 one-time payment relating to transition of her compensation from interim to permanent status. The Employment Agreement states that Ms. Bahrambeygui is eligible to participate in the Company’s bonus plan and to receive all other benefits offered to senior executives of the Company under the Company’s benefit practices and plans. The Employment Agreement specifies that for the 2019 fiscal year, Ms. Bahrambeygui is eligible to receive a target bonus of $291,800 (which is pro-rated based on service for the period commencing January 30, 2019 and ending August 31, 2019), and for the 2020 fiscal year, Ms. Bahrambeygui is eligible to receive a target bonus of $500,000.



In addition, the Employment Agreement provides that, except as specified below for the 2019 and 2020 fiscal years, Ms. Bahrambeygui will be eligible to receive for each fiscal year ending during the term an annual long-term incentive equity award.  The anticipated value of each award will be $2,500,000, with the number of shares subject to the award calculated based on the average closing price per share for the 30 day trading period prior to the date of grant.  Each award is anticipated to vest: (i) 1/3 based on achievement of performance metrics, such performance metrics to be substantially similar to those applicable to other executive officers; and (ii) 2/3 based on service, such service-based vesting to be substantially similar to the vesting terms applicable to other executive officers.  The actual value of the award for any fiscal year and the actual vesting terms for each such award, however, will be determined by the Compensation Committee of the Company’s Board of Directors in its sole discretion, acting in good faith, with consideration of all applicable facts and circumstances existing at that time.



Under the Employment Agreement, Ms. Bahrambeygui will be entitled to receive a grant of restricted stock of the Company with an aggregate value of $2,500,000 based on the average closing price per share for the 30-day trading period prior to the grant date (the “Bridge Grant”).  The Bridge Grant will be granted, subject to the Committee’s approval, within 30 days following the date of the Employment Agreement.  The Bridge Grant will vest, subject to Executive’s continued employment through each applicable vesting date, in accordance with the following schedule: (A) 20% on August 29, 2019; (B) 45% on August 29, 2020; and (C) 35% on August 29, 2021. 



Ms. Bahrambeygui also will be entitled to receive an award of restricted stock of the Company with an aggregate value of $1,458,900 based on the average closing price per share for the 30-day trading period prior to the date of grant (the “Fiscal 2019 Grant”). The Fiscal 2019 Grant will be granted, subject to the Compensation Committee’s approval, within 30 days following the date of the Employment Agreement. The Fiscal 2019 Grant will vest, subject to Ms. Bahrambeygui’s continued employment through each applicable vesting date, in accordance with the following schedule: (A) 50% on August 29, 2019; (B) 25% on August 29, 2020; and (C) 25% on August 29, 2021. 



 


 

Ms. Bahrambeygui also will be entitled to receive a grant of restricted stock and performance stock units of the Company with an aggregate value of $2,500,000 based on the average closing price per share for the 30-day trading period prior to the grant date (the “Fiscal 2020 Grant”).  The Fiscal 2020 Grant will be granted, subject to the Committee’s approval, concurrently with fiscal year 2020 grants to the Company’s executives, but in no event later than 30 days following the first anniversary of the date of the Employment Agreement.  In considering the Fiscal 2020 Grant, the Compensation Committee is required to take into account the facts that such award has been agreed in principle following good faith negotiations between Ms. Bahrambeygui and the Company and that Ms. Bahrambeygui entered into the Employment Agreement in reliance of the Compensation Committee’s stated intention to make the Fiscal 2020 Grant at the time and on the terms contemplated thereby.  The Fiscal 2020 Grant shall vest: (i) 1/3 based on achievement of performance metrics, such performance metrics to be substantially similar to those applicable to other executive officers; and (ii) 2/3 based on service, such service-based vesting to be substantially similar to the vesting terms applicable to the other executive officers. 



In connection with Ms. Bahrambeygui’s service as Interim Chief Executive Officer, Ms. Bahrambeygui was previously granted awards of restricted stock and performance stock units in the Company (the “Prior Grants”).  In the case of the Prior Grant of performance stock units, a pro rata portion of the service component of vesting applicable to such performance stock units will be deemed satisfied such that, subject to the Compensation Committee’s determination that the performance criteria for such performance stock units have been satisfied, 2,007 shares subject to such performance stock units will vest upon the Compensation Committee’s making such determination.  In the case of the Prior Grant of restricted stock, 4,074 shares will vest as of date of the new Employment Agreement.  All other vesting under the Prior Grants ceased effective as of January 29, 2019.



Upon termination of Ms. Bahrambeygui’s employment with the Company for any reason, she will be entitled to receive any earned but unpaid base salary, unpaid expense reimbursements and any vested benefits she may have under any employee benefit plan of the Company.



In the event that the Company terminates Ms. Bahrambeygui’s employment without “cause” or upon her death or “disability,” Ms. Bahrambeygui terminates her employment for “good reason” or the Company elects to cause the non-renewal of the Employment Agreement such that it expires at the end of its then-current term, Ms. Bahrambeygui also will be entitled to:



payment of an amount equal to one times base salary, payable over 24 months in conformity with the Company’s normal payroll period (less any earned income or disability payments received during such period, in the case of a termination upon her disability),

continued contribution of the premium cost for Ms. Bahrambeygui’s and her eligible dependents’ participation in the Company’s group health plan for 12 months,

payment of any earned but unpaid bonus for the year prior to termination and a pro rata bonus for the year of termination (payable when all other bonuses are paid).



In addition to the foregoing, in the event of termination of the Employment Agreement upon Ms. Bahrambeygui’s death or “disability,” the Fiscal 2019 Grant, the Fiscal 2020 Grant, the Bridge Grant and any other equity awards granted to Ms. Bahrmabeygui following the date of the Employment Agreement (collectively, the “Equity Awards”) will, to the extent then unvested, vest in accordance with the following: (i) 100% of all service-based Equity Awards will vest as of the termination date; and (ii) the service component of vesting of performance-based Equity Awards shall be deemed satisfied such that, subject to the Compensation Committee’s determination that the performance criteria for such Equity Awards have been satisfied, all performance-based awards shall vest upon the later of (A) the termination date and (B) the date on which the Compensation Committee determines that such performance criteria have been met.



In the event Ms. Bahrambeygui resigns her employment with the Company without “good reason” but provides at least 60 days’ notice of her resignation, she also will be entitled to receive payment of any accrued but any unpaid bonus for the year prior to termination (payable when all other bonuses are paid).



 


 

The foregoing severance benefits are the exclusive benefits that would be payable to Ms. Bahrambeygui under her Employment Agreement by reason of her termination.  Payment of the severance benefits is conditioned on Ms. Bahrambeygui’s continued compliance with her obligations with respect to confidentiality, non-solicitation of employees and non-interference with the Company’s customers and contracts and Ms. Bahrambeygui (or her estate) executing and delivering to the Company a full release of all claims in a form reasonably acceptable to the Company.



This description of the Employment Agreement is qualified in its entirety by the terms set forth in the definitive agreement attached hereto as an exhibit.







Item 9.01. Exhibits.





 

 

 



(d)

The following exhibit is furnished herewith:



 

 

 



Exhibit
No.

 

Description



10.1

 

Employment Agreement dated March 4, 2019 between Sherry S. Bahrambeygui and the Company



 

 

 



 


 

SIGNATURES



Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.





 

 

 

 



Date:   March 7 ,   201 9

 

/S/   FRANCISCO VELASCO

 



 

 

Francisco Velasco

 



 

 

Executive   Vice   President ,   General Counsel and Secretary

 





 


EMPLOYMENT AGREEMENT

This Employment Agreement (this “ Agreement ”) is made as of March 4, 2019 (the “ Execution Date ”), between PriceSmart, Inc., a Delaware corporation (the “ Company ”), and Sherry S. Bahrambeygui (the “ Executive ”).

WHEREAS , the Company previously retained the Executive as its Interim Chief Executive Officer in accordance with the Employment Agreement between the Company and the Executive, dated November 20, 2018 (the “ Prior Agreement ”).

WHEREAS , the Company desires to retain the Executive, and the Executive desires to be retained and employed by the Company, as the Company’s Chief Executive Officer on the terms contained in this Agreement.

NOW, THEREFORE , in consideration of the mutual covenants and agreements herein contained and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:

1. Position and Duties .

a. The Executive shall serve as the Company’s Chief Executive Officer, reporting to the Company’s Board of Directors (the “ Board ”).

b. The Executive shall perform those services customary to this office and such other lawful duties that the Board may reasonably assign to her.  The Executive shall devote all of her business time and best efforts to the performance of her duties under this Agreement and shall be subject to, and shall comply with, the Company’s policies, practices and procedures and all codes of ethics or business conduct applicable to her position, as in effect from time to time.  Notwithstanding the foregoing, the Executive shall be entitled to (i) serve as a member of the board of directors of a reasonable number of other companies, subject to the advance approval of the Board, which approval shall not be unreasonably withheld, (ii) serve on civic, charitable, educational, religious, public interest or public service boards, subject to the advance approval of the Board, which approval shall not be unreasonably withheld, and (iii) manage the Executive’s personal and family investments, in each case, to the extent such activities do not materially interfere, as determined by the Board in good faith, with the performance of the Executive’s duties and responsibilities hereunder.

2. Term .  This Agreement and the Executive’s employment pursuant to this Agreement shall begin on January 30, 2019 (the “ Effective Date ”) and end on August 31, 2020 (the “ Expiration Date ”), unless terminated earlier by the Company or the Executive pursuant to Section 4 of this Agreement (the “ Term ”).  This Agreement shall renew automatically for successive one-year Terms commencing on the day following the Expiration Date and ending on the anniversary of Expiration Date (which date will become the new Expiration Date), unless either the Company or Executive notifies the other, in writing and in accordance with Section 17 herein, at least sixty (60) days prior to the Expiration Date, that either the Company or Executive wishes to terminate this Agreement (in which case this Agreement shall terminate in accordance with Section 4(a)).

3. Compensation and Related Matters .

a. Base Salary .  For the period during the Term following the Execution Date, the Executive’s annual base salary shall be $1,000,000 (the “ Base Salary ”).  The Base Salary shall be payable


 

in accordance with the Company’s normal payroll procedures in effect from time to time and may be increased, but not decreased, at the discretion of the Company.

b. Transition Payment . The Company shall pay the Executive an amount equal to $27,960.22 (the “ Transition Payment ”).  The Transition Payment will be payable in a single lump sum on the first payroll date following the Execution Date.

c. Bonus .

(i) The Executive shall be eligible to receive for each fiscal year ending during the Term an annual performance-based bonus (the “ Bonus ”).  The target bonus opportunity for each fiscal year is anticipated to be $500,000, payable in cash in accordance with, and subject to the terms and conditions of, the Company’s bonus or other cash incentive program (each, a “ Bonus Program ”), if either (or both) are then applicable to the Executive.  The actual target Bonus for each fiscal year and the actual amount of any Bonus awarded, if any, shall be determined by the Compensation Committee of the Board (the “ Committee ”), subject to the Committee’s discretion acting in good faith with consideration of all applicable facts and circumstances existing at that time and based on the achievement of performance metrics established by the Committee for the applicable fiscal year, which initially will be allocated 50% to financial metrics and 50% to specific operational or strategic goals set by the Committee in its discretion.  The Committee will establish the performance metrics for each fiscal year, together with the applicable range of estimated payouts denominated in dollars (threshold, target and maximum amount), within sixty (60) days following the start of the fiscal year.  Over time, the Committee may evolve the Bonus metrics to be wholly or predominantly financial.

(ii) For the 2019 fiscal year, Executive shall be eligible to receive a target Bonus of $291,800 (which is pro-rated based on service for the period commencing January 30, 2019 and ending August 31, 2019), with the performance metrics allocated 50% to financial metrics and 50% to specific operational or strategic goals set by the Committee in its discretion.  The Committee will establish the performance metrics for the 2019 fiscal year, together with the applicable range of estimated payouts denominated in dollars (threshold, target and maximum amount), within sixty (60) days following the Execution Date. 

(iii) For the 2020 fiscal year, Executive shall be eligible to receive a target Bonus of $500,000, with the performance metrics allocated 50% to financial metrics and 50% to specific operational or strategic goals set by the Committee in its discretion.  The Committee will establish the performance metrics for the 2019 fiscal year, together with the applicable range of estimated payouts denominated in dollars (threshold, target and maximum amount), within sixty (60) days following the start of fiscal year 2020.

(iv) In the case of any Bonus compensation payable to the Executive as part of a Bonus Program applicable to other executives, satisfaction of performance targets shall be determined and payments shall be made in accordance with the Company’s Bonus Program, subject to the condition that the Executive remain employed by the Company through the end of the relevant fiscal year (except as otherwise provided herein).  In the case of any Bonus compensation payable to the Executive that is not part of a Bonus Program applicable to other executives, the Compensation Committee will determine if the metrics were met in whole or in part after finalization of the Company’s financial results, or completion of the operational and strategic goals at the end of the fiscal year, as applicable, and, if earned, the Bonus will be payable at the end of each fiscal year or as soon as practicable thereafter.

2

 


 

d. Long-Term Incentive Equity

(i) Annual Award .  Except as specified below for the 2019 and 2020 fiscal years, the Executive shall be eligible to receive for each fiscal year ending during the Term an annual long-term incentive equity award.  The anticipated value of each award will be $2,500,000, with the number of shares subject to the award calculated based on the average closing price per share for the thirty (30) day trading period prior to the date of grant.  Each award is anticipated to vest: (i) 1/3 based on achievement of performance metrics, such performance metrics to be substantially similar to those applicable to other executive officers; and (ii) 2/3 based on service, such service-based vesting to be substantially similar to the vesting terms applicable to other executive officers.  The actual value of the award for any fiscal year and the actual vesting terms for each such award, however, shall be determined by the Committee in its sole discretion, acting in good faith, with consideration of all applicable facts and circumstances existing at that time.

(ii) Bridge Grant . The Executive shall be entitled to receive a grant of restricted stock of the Company with an aggregate value of $2,500,000 based on the average closing price per share for the thirty (30) day trading period prior to the grant date (the “ Bridge Grant ”).  The Bridge Grant shall be granted, subject to the Committee’s approval, within thirty (30) days following the Execution Date.  The Bridge Grant shall vest, subject to Executive’s continued employment through each applicable vesting date, in accordance with the following schedule: (A) 20% on August 29, 2019; (B) 45% on August 29, 2020; and (C) 35% on August 29, 2021.  The Bridge Grant shall be governed by and shall be subject to the terms and conditions set forth in the Company’s 2013 Equity Incentive Award Plan (the “ Plan ”) and an award agreement to be provided by the Company.

(iii) 2019 Fiscal Year Grant . The Executive shall be entitled to receive an award of restricted stock of the Company with an aggregate value of $1,458,900 based on the average closing price per share for the thirty (30) day trading period prior to the date of grant (the “ Fiscal 2019 Grant ”). The Fiscal 2019 Grant shall be granted, subject to the Committee’s approval, within thirty (30) days following the Execution Date. The Fiscal 2019 Grant shall vest, subject to Executive’s continued employment through each applicable vesting date, in accordance with the following schedule: (A) 50% on August 29, 2019; (B) 25% on August 29, 2020; and (C) 25% on August 29, 2021.  The Fiscal 2019 Grant shall be governed by and shall be subject to the terms and conditions set forth in the Plan and an award agreement to be provided by the Company.

(iv) 2020 Fiscal Year Grant . The Executive shall be entitled to receive a grant of restricted stock and performance stock units of the Company with an aggregate value of $2,500,000 based on the average closing price per share for the thirty (30) day trading period prior to the grant date (the “ Fiscal 2020 Grant ”).  The Fiscal 2020 Grant shall be granted, subject to the Committee’s approval, concurrently with fiscal year 2020 grants to the Company’s executives, but in no event later than thirty (30) days following the first anniversary of the Effective Date.  In considering the Fiscal 2020 Grant, the Committee shall take into account the facts that such award has been agreed in principle following good faith negotiations between the Executive and the Company and that the Executive entered into this Agreement in reliance of the Committee’s stated intention to make the Fiscal 2020 Grant at the time and on the terms contemplated hereby.  The Fiscal 2020 Grant shall vest: (i) 1/3 based on achievement of performance metrics, such performance metrics to be substantially similar to those applicable to other executive officers; and (ii) 2/3 based on service, such service-based vesting to be substantially similar to the vesting terms applicable to the other executive officers.  The Fiscal 2020 Grant shall be governed by and shall be subject to the terms and conditions set forth in the Plan and an award agreement to be provided by the Company.

3

 


 

(v) Vesting of Prior Grants . In connection with the Executive’s service as Interim Chief Executive Officer, the Executive was previously granted awards of restricted stock and performance stock units in the Company (the “ Prior Grants ”) under the Plan and pursuant to the Performance Stock Unit Agreement between the Company and the Executive, dated November 16, 2018 and the Restricted Stock Agreement between the Company and the Executive, dated November 16, 2018 (collectively, the “ Prior Grant Documents ”).  In the case of the Prior Grant pursuant to the Performance Stock Unit Agreement, a pro rata portion of the service component of vesting applicable to such performance stock units shall be deemed satisfied such that, subject to the Committee’s determination that the performance criteria for such performance stock units have been satisfied, 2,007 shares subject to such performance stock units will vest upon the Committee’s making such determination.  In the case of the Prior Grant pursuant to the Restricted Stock Agreement 4,074 shares shall vest as of the Execution Date.  In consideration for the benefits and promises set forth in this Agreement and notwithstanding anything in the Prior Grant Documents or the Plan to the contrary, all other vesting under the Prior Grants shall cease effective as of January 29, 2019.

e. Business Expenses .  During the Term, the Executive shall be entitled to receive prompt reimbursement for all reasonable business expenses incurred by her in performing services hereunder, in accordance with the policies and procedures then in effect and established by the Company for its senior executive officers.

f. Other Benefits .  During the Term and subject to any contribution therefor required of employees of the Company, the Executive shall be eligible to participate in all equity, pension, savings and retirement plans, welfare and insurance plans, practices, policies, programs and perquisites of employment applicable generally to other senior executives of the Company, except to the extent any employee benefit plan provides for benefits otherwise provided to the Executive hereunder (e.g., bonuses and severance).  Such participation shall be subject to (i) requirements of applicable law, (ii) the terms of the applicable plan documents, (iii) generally applicable Company policies, and (iv) the discretion of the Board or any administrative or other committee provided for under or contemplated by such plan.  The Executive shall have no recourse against the Company under this Agreement in the event that the Company should alter, modify, add to or eliminate any or all of its employee benefit plans.

g. Vacation; Holidays .  During the Term, the Executive shall be entitled to take vacation and other holiday time in accordance with the policies applicable to senior executives of the Company generally. 

4. Termination .  The Executive’s employment may be terminated prior to the expiration of the Term hereof and this Agreement may be terminated under the following circumstances:

a. Intent Not to Renew .  This Agreement shall terminate upon the end of the then-current Term if either the Company or the Executive timely delivers notice of an intent not to renew this Agreement, as set forth in Sections 2 and 17 herein.

b. Death .  The Executive’s employment shall terminate upon her death.

c. Disability .  The Company may terminate the Executive’s employment if the Executive becomes subject to a Disability.  For purposes of this Agreement, “ Disability ” means the Executive is unable to perform the essential functions of her position, with or without a reasonable accommodation, for a period of 90 consecutive calendar days or 180 non-consecutive calendar days within any rolling 12 month period.

4

 


 

d. Termination by Company for Cause .  The Company may terminate the Executive’s employment for Cause.  For purposes of this Agreement, “ Cause ” means: (i) the Executive’s repeated and habitual failure to perform her duties or obligations hereunder; (ii) engaging in any act that has a direct, substantial and adverse effect on the Company’s interests; (iii) personal dishonesty, willful misconduct, or breach of fiduciary duty involving personal profit; (iv) intentional failure to perform her stated duties; (v) willful violation or reckless disregard of any law, rule or regulation which materially adversely affects her ability to discharge her duties or has a direct, substantial and adverse effect on the Company’s interests; (vi) any material breach of this Agreement by Executive; or (vii) conduct authorizing termination under Cal. Labor Code § 2924.

e. Termination by the Company without Cause .  The Company may terminate the Executive’s employment at any time without Cause upon 30 days’ prior written notice.

f. Termination by the Executive .  The Executive may terminate her employment at any time for any reason other than a Good Reason, upon 60 days’ prior written notice.

g. Termination by the Executive for Good Reason .  The Executive may terminate her employment for Good Reason.  For purposes of this Agreement, “ Good Reason ” means the existence of any one or more of the following conditions without the Executive’s consent, provided Executive submits written notice to the Company within 45 days after such condition(s) first arose, specifying the condition(s): (i) a material change in or reduction of the Executive’s authority, duties and responsibilities, or the assignment to the Executive of duties materially inconsistent with the Executive’s position with the Company; (ii) a material reduction in the Executive’s then-current compensation; or (iii) the requirement that Executive relocate to an office location more than fifty (50) miles from San Diego, California. The Executive’s continued employment subsequent to an event that may constitute Good Reason shall not be deemed to be a waiver of her rights under this provision (subject to the 45-day time period specified herein).  Upon receipt of written notice from the Executive regarding a condition constituting Good Reason, the Company shall then have 30 days to correct the condition (the “ Cure Period ”).  If such condition is not corrected by the last day of the Cure Period, the Executive’s resignation for Good Reason shall become effective on the 31st day following the Executive’s written notice specifying the events giving rise to a Good Reason termination.

h. Termination Date .  The “ Termination Date ” means: (i) if the Executive’s employment is terminated by her death under Section 4(b), the date of her death; (ii) if the Executive’s employment is terminated on account of her Disability under Section 4(c), the date on which the Company provides the Executive a written termination notice; (iii) if the Company terminates the Executive’s employment for Cause under Section 4(d), the date on which the Company provides the Executive a written termination notice; (iv) if the Company terminates the Executive’s employment without Cause under Section 4(e), 30 days after the date on which the Company provides the Executive a written termination notice; (v) if the Executive resigns her employment without Good Reason under Section 4(f), 60 days after the date on which the Executive provides the Company a written termination notice; and (vii) if the Executive resigns her employment with Good Reason under Section 4(g), the 31st day following the day the Executive provides the Company with written notice of the conditions constituting same, if the Company has not cured such conditions by the 30th day.

i. Actions on Termination Date . Executive agrees that on or before the Termination Date, Executive shall resign from all board and officer positions with the Company and its subsidiaries and affiliates, and this Agreement shall constitute an agreement to so resign upon the effective date of Executive’s termination.

5

 


 

j. Access to Company Property . Upon delivery of any notice of intent not to renew or any notice of termination, the Company may, immediately or at any time after such notice, preclude Executive from having access to the Company’s facilities, equipment, computers and any related processes and property.

5. Compensation upon Termination .

a. Accrued Obligations Payable upon any Termination .  Upon the termination of Executive’s employment with the Company for any reason, the Company shall pay or provide to the Executive (or Executive’s estate) the following amounts through the Termination Date: any earned but unpaid Base Salary, unpaid expense reimbursements, and any vested benefits the Executive may have under any employee benefit plan of the Company (the “ Accrued Obligations ”) on or before the time required by law but in no event more than 30 days after the Executive’s Termination Date.

b. Termination by the Company without Cause, or by the Executive with Good Reason, or Due to the Company’s Delivery to Executive of a Notice of Intent Not to Renew .  If, prior to the expiration of the Term, the Executive’s employment is terminated by the Company without Cause pursuant to Section 4(e), or the Executive terminates her employment for Good Reason pursuant to Section 4(g), or the Executive’s employment terminates at the end of the then-current Term following the Company’s delivery to Executive of a notice of intent not to renew pursuant to section 4(a), then the Executive shall be entitled to the following, including any pro rata portion thereof earned as of the Termination Date subject to Section 6:

(i) The Company shall pay the Executive any earned but unpaid Bonus with respect to any completed fiscal year immediately preceding the Termination Date;

(ii) The Company shall pay the Executive a Bonus for the fiscal year of the Company in which the Termination Date occurs, which shall be pro rated for the portion of such fiscal year that the Executive is employed by the Company.  The amount of such Bonus, prior to pro ration, shall be equal to the Bonus that the Executive would have earned under the Company’s Bonus Program for the fiscal year of the Company in which the Termination Date occurs had the Executive remained in its employment, contingent on the relevant annual bonus plan performance goals for the year in which Executive terminates having been obtained.  Such Bonus shall be paid on the date the bonuses are paid to other Executives pursuant to the Company Bonus Program, without reference to the actual Termination Date;

(iii) Subject to the timely election of continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“ COBRA ”), the Company shall continue to contribute to the premium cost of the Executive’s participation and that of her eligible dependents in the Company’s group health plan (to the extent permitted under applicable law and the terms of such plan) which covers the Executive (and the Executive’s eligible dependents) for a period of twelve (12) months, provided (x) the Executive pays the remainder of the premium cost of such participation by payroll deduction (if any), (y) the Executive is eligible and remains eligible for COBRA coverage; and (z) the Executive reports to the Company on a monthly basis any health care premium payments received from another employer during such twelve-month period, as such amounts shall be deducted from any Company-paid COBRA premium contribution.  If the reimbursement of any COBRA premiums would violate the nondiscrimination rules or cause the reimbursement of claims to be taxable under the Patient Protection and Affordable Care Act of 2010, together with the Health Care and Education Reconciliation Act of 2010 (collectively, the “ Act ”) or Section 105(h) of the Code, the Company- paid premiums shall be treated as taxable payments and be subject to imputed income tax treatment

6

 


 

to the extent necessary to eliminate any discriminatory treatment or taxation under the Act or Section 105(h) of the Code.  If the Executive’s participation or that of her eligible dependents would give rise to penalties or taxes against the Company under the Act, as determined by the Company in its sole discretion, the Company shall instead make cash payments to the Executive over the same period in monthly installments in an amount equal to the Company’s portion of the monthly cost of providing such benefits under its group health plan for such period; and

(iv) The Company shall pay the Executive severance in an amount equal to one times the Base Salary at the rate in effect on the Termination Date (but without giving effect to any reduction if one or all of the bases for the Executive’s resignation for Good Reason is a reduction in compensation) in twenty-four (24) equal installments (totaling twelve months) as set forth in Section 6.

c. Termination by the Company for Disability .  If, prior to the expiration of the Term, the Executive’s employment is terminated by the Company for Disability pursuant to Section 4(c), then the Executive shall be entitled to the following, subject to Section 6:

(i) The Company shall pay the Executive any earned but unpaid Bonus with respect to any completed fiscal year immediately preceding the Termination Date;

(ii) The Company shall pay the Executive a Bonus for the fiscal year of the Company in which the Termination Date occurs, which shall be pro rated for the portion of such fiscal year that the Executive is employed by the Company.  The amount of such Bonus, prior to pro ration, shall be equal to the Bonus that the Executive would have earned under the Company’s Bonus Program for the fiscal year of the Company in which the Termination Date occurs had the Executive remained in its employment, contingent on the relevant annual bonus plan performance goals for the year in which Executive terminates having been obtained.  Such Bonus shall be paid on the date the bonuses are paid to other Executives pursuant to the Company Bonus Program, without reference to the actual Termination Date;

(iii) Subject to the timely election of continuation coverage under the COBRA, the Company shall continue to contribute to the premium cost of the Executive’s participation and that of her eligible dependents in the Company’s group health plan (to the extent permitted under applicable law and the terms of such plan) which covers the Executive (and the Executive’s eligible dependents) for a period of twelve (12) months, provided (x) the Executive pays the remainder of the premium cost of such participation by payroll deduction (if any), (y) the Executive is eligible and remains eligible for COBRA coverage; and (z) the Executive reports to the Company on a monthly basis any health care premium payments received from another employer during such twelve-month period, as such amounts shall be deducted from any Company-paid COBRA premium contribution. If the reimbursement of any COBRA premiums would violate the nondiscrimination rules or cause the reimbursement of claims to be taxable under the Act or Section 105(h) of the Code, the Company paid premiums shall be treated as taxable payments and be subject to imputed income tax treatment to the extent necessary to eliminate any discriminatory treatment or taxation under the Act or Section 105(h) of the Code.  If the Executive’s participation or that of her eligible dependents would give rise to penalties or taxes against the Company under the Act, as determined by the Company in its sole discretion, the Company shall instead make cash payments to the Executive over the same period in monthly installments in an amount equal to the Company’s portion of the monthly cost of providing such benefits under its group health plan for such period;

(iv) The Company shall pay the Executive severance in an amount equal to one times the Base Salary at the rate in effect on the Termination Date in twenty-four (24) equal

7

 


 

installments (totaling twelve months) as set forth in Section 6; provided, however , that the Company shall deduct from such severance any earned income (other than passive investment income) or disability payments received by Executive during such twelve-month period, and as to which Executive covenants to report to the Company such income on a bi-weekly basis; and

(v) The Fiscal 2019 Grant, the Fiscal 2020 Grant, the Bridge Grant and any other equity awards granted to Executive under the Plan following the Effective Date (collectively, the “ Equity Awards ”) shall, to the extent then unvested, vest in accordance with the following: (A) 100% of all service-based Equity Awards will vest as of the Termination Date; and (B) the service component of vesting of performance-based Equity Awards shall be deemed satisfied such that, subject to the Committee’s determination that the performance criteria for such Equity Awards have been satisfied, all performance-based awards shall vest upon the later of (x) the Termination Date and (y) the date on which the Committee determines that such performance criteria have been met.

d. Termination by the Company Due to Executive’s Death .  If, prior to the expiration of the Term, the Executive’s employment is terminated due to Executive’s death pursuant to Section 4(b), then the Executive’s estate shall be entitled to the following, subject to Section 6:

(i) The Company shall pay the Executive’s estate any earned but unpaid Bonus with respect to any completed fiscal year immediately preceding the Termination Date;

(ii) The Company shall pay the Executive’s estate a Bonus for the fiscal year of the Company in which the Termination Date occurs, which shall be pro rated for the portion of such fiscal year that the Executive is employed by the Company.  The amount of such Bonus, prior to pro ration, shall be equal to the Bonus that the Executive would have earned under the Company’s Bonus Program for the fiscal year of the Company in which the Termination Date occurs had the Executive remained in its employment, contingent on the relevant annual bonus plan performance goals for the year in which Executive terminates having been obtained.  Such Bonus shall be paid on the date the bonuses are paid to other Executives pursuant to the Company Bonus Program, without reference to the actual Termination Date;

(iii) Subject to the timely election of continuation coverage under the COBRA, the Company shall continue to contribute to the premium cost of Executive’s eligible dependents’ in the Company’s group health plan (to the extent permitted under applicable law and the terms of such plan) for a period of twelve (12) months, provided (x) the Executive’s estate pays the remainder of the premium cost of such participation by payroll deduction (if any), and (y) the Executive’s dependents remain eligible for COBRA coverage.  If the reimbursement of any COBRA premiums would violate the nondiscrimination rules or cause the reimbursement of claims to be taxable under the Act or Section 105(h) of the Code, the Company paid premiums shall be treated as taxable payments and be subject to imputed income tax treatment to the extent necessary to eliminate any discriminatory treatment or taxation under the Act or Section 105(h) of the Code.  If the participation of Executive’s eligible dependents would give rise to penalties or taxes against the Company under the Act, as determined by the Company in its sole discretion, the Company shall instead make cash payments to the Executive’s estate over the same period in monthly installments in an amount equal to the Company’s portion of the monthly cost of providing such benefits under its group health plan for such period; and

(iv) The Equity Awards shall, to the extent then unvested, vest in accordance with the following: (A) 100% of all service-based Equity Awards will vest as of the Termination Date; and (B) the service component of vesting of performance-based Equity Awards shall be

8

 


 

deemed satisfied such that, subject to the Committee’s determination that the performance criteria for such Equity Awards have been satisfied, all performance-based awards shall vest upon the later of (x) the Termination Date and (y) the date on which the Committee determines that such performance criteria have been met.

e. Termination by the Company Due to Cause or Due to Executive’s Failure to Renew or by Executive without Good Reason and Without Notice .  If, prior to the expiration of the Term, the Company terminates Executive’s employment for Cause pursuant to Section 4(d), or the Executive’s employment terminates following the Executive’s delivery to the Company of a notice of intent not to renew pursuant to Section 4(a), or by Executive without Good Reason and without notice pursuant to Section 4(f), then the Executive shall be entitled only to the Accrued Obligations in Section 5(a) and shall be entitled to no other benefits from the Company.

f. Termination by Executive without Good Reason and With Notice . If, prior to the expiration of the Term, Executive terminates without Good Reason but provides the minimum of sixty (60) days’ notice of such termination pursuant to Section 4(f), and such notice makes the Termination Date at or after the time period encompassed by the relevant bonus year, then in addition to the Accrued Obligations set forth in Section 5(a), Executive shall be entitled to Executive’s earned but unpaid Bonus with respect to any completed fiscal year immediately preceding the Termination Date.  In such event, the Bonus shall be paid on the date the bonuses are paid to other Executives pursuant to the applicable Bonus Program, without reference to the actual Termination Date.

6. Release; Payment .  Except for the Accrued Obligations provided for in Section 5(a), any other payments and benefits provided for in Section 5 shall be conditioned on (a) the Executive’s continued compliance with the obligations of the Executive under Sections 8 and 9 and (b) the Executive or, in the event of her death, her estate, executing and delivering to the Company a separation agreement which includes a full release of all claims that the Executive, her heirs and assigns may have against the Company, its affiliates and subsidiaries and each of their respective directors, officers, employees and agents, in a form reasonably acceptable to the Company, which shall include an affirmation by Executive that Executive shall fully comply with Sections 8 and 9 of this Agreement (the “ Release ”).  The Release must become enforceable and irrevocable on or before the sixtieth (60th) day following the Termination Date.  If the Executive (or her estate) fails to execute without revocation the Release, she shall be entitled to the Accrued Obligations only and no other benefits.  The installments of severance provided under Sections 5(b)(iii) and 5(c)(iii) shall commence in the calendar month following the month in which the Release becomes enforceable and irrevocable.  If, however, the sixty (60) day period in which the Release must become enforceable and irrevocable begins in one year and ends in the following year, the Company shall commence payment of the severance installments in the second year in the later of January and the first calendar month following the month in which the Release becomes effective and irrevocable.  The first installment shall include, however, all amounts that would otherwise have been paid to the Executive between the Termination Date and the Executive’s receipt of the first installment, assuming the first installment would otherwise have been paid in the month following the month in which the Termination Date occurs.

7. Section 409A Compliance .

a. All in-kind benefits provided and expenses eligible for reimbursement under this Agreement shall be provided by the Company or incurred by the Executive during the time periods set forth in this Agreement.  All reimbursements shall be paid as soon as administratively practicable, but in no event shall any reimbursement be paid after the last day of the taxable year following the taxable year in which the expense was incurred.  The amount of in-kind benefits provided or reimbursable expenses incurred in one taxable year shall not affect the in-kind benefits to be provided or the expenses eligible for

9

 


 

reimbursement in any other taxable year.  Such right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit.

b. To the extent that any of the payments or benefits provided for in Section 5 are deemed to constitute non-qualified deferred compensation benefits subject to Section 409A of the United States Internal Revenue Code (the “ Code ”), the following interpretations apply to Section 5:

(i) Any termination of the Executive’s employment triggering payment of benefits under Section 5 must constitute a “separation from service” under Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. § 1.409A-l(h) before distribution of such benefits can commence.  To the extent that the termination of the Executive’s employment does not constitute a separation of service under Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. §1.409A- 1(h) (as the result of further services that are reasonably anticipated to be provided by the Executive to the Company or any of its parents, subsidiaries or affiliates at the time the Executive’s employment terminates), any benefits payable under Section 5 that constitute deferred compensation under Section 409A of the Code shall be delayed until after the date of a subsequent event constituting a separation of service under Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. §1.409A-1(h).  For purposes of clarification, this Section 7(b)(i) shall not cause any forfeiture of benefits on the Executive’s part, but shall only act as a delay until such time as a “separation from service” occurs.

(ii) Because the Executive is a “specified employee” (as that term is used in Section 409A of the Code and regulations and other guidance issued thereunder) on the date her separation from service becomes effective, any benefits payable under Section 5(b)(iii) or 5(c)(iii) that constitute non-qualified deferred compensation under Section 409A of the Code shall be delayed until the earlier of (A) the business day following the six-month anniversary of the date her separation from service becomes effective, and (B) the date of the Executive’s death, but only to the extent necessary to avoid such penalties under Section 409A of the Code.  On the earlier of (A) the business day following the six-month anniversary of the date her separation from service becomes effective, and (B) the Executive’s death, the Company shall pay the Executive in a lump sum the aggregate value of the non-qualified deferred compensation that the Company otherwise would have paid the Executive prior to that date under Section 5 of this Agreement.

(iii) It is intended that each installment of the payments and benefits provided under Section 5 of this Agreement shall be treated as a separate “payment” for purposes of Section 409A of the Code.  In particular, the installment severance payments described in Section 7(b)(ii) of this Agreement shall be divided into two portions.  That number of installments commencing on the first payment date set forth in Section 7 of this Agreement that are in the aggregate less than two times the applicable compensation limit under Section 401(a)(17) of the Code for the year in which the Termination Date occurs (provided the termination of the Executive’s employment is also a separation from service) shall be payable in accordance with Treas. Reg. § 1.409A-l(b)(9)(iii) as an involuntary separation plan.  The remainder of the installments shall be paid in accordance with Sections 7(b)(i) and (ii) above.

8. Confidentiality and Restrictive Covenants .

a. The Executive acknowledges that:

(i) the Company (which, for purposes of this Section 8 shall include the Company and each of its subsidiaries and affiliates) operates membership warehouse clubs in Central America, Colombia and the Caribbean (the “ Business ”);

10

 


 

(ii) the Company is dependent on the efforts of a certain limited number of persons who have developed, or will be responsible for developing the Company’s Business;

(iii) the Company’s Business is international in scope;

(iv) the Business in which the Company is engaged is intensely competitive and that Executive’s employment by the Company will require that she have access to and knowledge of nonpublic confidential information of the Company and the Company’s Business, including, but not limited to, certain/all of the Company’s products, plans for creation, acquisition or disposition of products or publications, strategic and expansion plans, formulas, research results, marketing plans, financial status and plans, budgets, forecasts, profit or loss figures, distributors and distribution strategies, pricing strategies, improvements, sales figures, contracts, agreements, then existing or then prospective suppliers and sources of supply and customer lists, undertakings with or with respect to the Company’s customers or prospective customers, and patient information, product development plans, rules and regulations, personnel information and trade secrets of the Company, all of which are of vital importance to the success of the Company’s business (collectively, “ Confidential Information ”);

(v) the direct or indirect disclosure of any Confidential Information would place the Company at a serious competitive disadvantage and would do serious damage, financial and otherwise, to the Company’s business;

(vi) by her training, experience and expertise, the Executive’s services to the Company is special and unique;

(vii) the covenants and agreements of the Executive contained in this Section 8 are essential to the business and goodwill of the Company; and

(viii) if the Executive leaves the Company’s employ to work for a competitive business, in any capacity, it would cause the Company irreparable harm.

b. Covenant against Disclosure .  All Confidential Information relating to the Business is, shall be and shall remain the sole property and confidential business information of the Company, free of any rights of the Executive.  The Executive shall not make any use of the Confidential Information except in the performance of her duties hereunder and shall not disclose any Confidential Information to third parties, without the prior written consent of the Company.

c. Return of Company Documents .  On the Termination Date or on any prior date upon the Company’s written demand, the Executive will return all memoranda, notes, lists, records, property and other tangible product and documents concerning the Business, including all Confidential Information, in her possession, directly or indirectly, that is in written or other tangible form (together with all duplicates thereof) and that she will not retain or furnish any such Confidential Information to any third party, either by sample, facsimile, film, audio or video cassette, electronic data, verbal communication or any other means of communication.

d. Further Covenant . During the Term and through the second anniversary of the Termination Date, the Executive shall not, directly or indirectly, take any of the following actions, and, to the extent the Executive owns, manages, operates, controls, is employed by or participates in the ownership, management, operation or control of, or is connected in any manner with, any business, the Executive will use her best efforts to ensure that such business does not take any of the following actions:

11

 


 

(i) Persuade or attempt to persuade any customer of the Company to cease doing business with the Company, or to reduce the amount of business any customer does with the Company, to the extent any such action involves the use of a Company trade secret;

(ii) Take any action that interferes with the Company’s contracts or prospective contracts with its customers, to the extent any such action involves the use of a Company trade secret;  or

(iii) Persuade or attempt to persuade any employee or independent contractor of the Company to leave the service of the Company, where such individual was an employee or independent contractor of the Company within one (1) year prior to the Executive’s Termination Date.

e. Enforcement .  The Executive acknowledges and agrees that any breach by her of any of the provisions of this Section 8 (the “ Restrictive Covenants ) would result in irreparable injury and damage for which money damages would not provide an adequate remedy. Therefore, if the Executive breaches or threatens to commit a breach of any of the provisions of Section 8, the Company shall have the ability to seek the following rights and remedies, each of which rights and remedies shall be independent of the other and severally enforceable, and all of which rights and remedies shall be in addition to, and not in lieu of, any other rights and remedies available to the Company under law or in equity (including, without limitation, the recovery of damages): (i) the right and remedy to have the Restrictive Covenants specifically enforced (without posting bond and without the need to prove damages) by any court having equity jurisdiction, including, without limitation, the right to an entry against the Executive of restraining orders and injunctions (preliminary, mandatory, temporary and permanent) against violations, threatened or actual, and whether or not then continuing, of such covenants; and (ii) the right and remedy to require the Executive to account for and pay over to the Company all compensation, profits, monies, accruals, increments or other benefits (collectively, “ Benefits ) derived or received by her as the result of any transactions constituting a breach of the Restrictive Covenants, and the Executive shall account for and pay over such Benefits to the Company and, if applicable, its affected subsidiaries and/or affiliates.  The Executive agrees that in any action seeking specific performance or other equitable relief, she will not assert or contend that any of the provisions of this Section 8 are unreasonable or otherwise unenforceable. Other than a material breach of this Agreement, the existence of any claim or cause of action by the Executive, whether predicated on this Agreement or otherwise, shall not constitute a defense to the enforcement of the Restrictive Covenants.

f. Defend Trade Secrets Act of 2016 . Under the Defend Trade Secrets Act of 2016, the Company hereby provides notice and Executive hereby acknowledges that Executive may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (i) is made (A) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney and (B) is solely for the purpose of reporting or investigating a suspected violation of law; or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.

9. Intellectual Property .

a. Works for Hire .  All creations, inventions, ideas, designs, software, copyrightable materials, trademarks, and other technology and rights (and any related improvements or modifications), whether or not subject to patent or copyright protection (collectively, “ Creations ”), relating to any activities of the Company which were, are, or will be conceived by the Executive or developed by the Executive in the course of her employment or other services with the Company, whether conceived alone or with others and whether or not conceived or developed during regular business hours, and if based on Confidential Information, after the termination of the Executive’s employment, shall be the sole property of the Company

12

 


 

and, to the maximum extent permitted by applicable law, shall be deemed “works made for hire” as that term is used in the United States Copyright Act.  The Executive agrees to assign and hereby does assign to the Company all Creations conceived or developed from the start of this employment with the Company through to the Termination Date, and after the Termination Date if the Creation incorporates or is based on any Confidential Information.

b. Assignment .  To the extent, if any, that the Executive retains any right, title or interest with respect to any Creations delivered to the Company or related to her employment with the Company, the Executive hereby grants to the Company an irrevocable, paid-up, transferable, sub-licensable, worldwide right and license: (i) to modify all or any portion of such Creations, including, without limitation, the making of additions to or deletions from such Creations, regardless of the medium (now or hereafter known) into which such Creations may be modified and regardless of the effect of such modifications on the integrity of such Creations; and (ii) to identify the Executive, or not to identify her, as one or more authors of or contributors to such Creations or any portion thereof, whether or not such Creations or any portion thereof have been modified.  The Executive further waives any “moral” rights, or other rights with respect to attribution of authorship or integrity of such Creations that she may have under any applicable law, whether under copyright, trademark, unfair competition, defamation, right of privacy, contract, tort or other legal theory.

Notwithstanding the foregoing, pursuant to California Labor Code Section 2870, the foregoing shall not apply to, and Executive shall not be required to assign to the Company, an invention that Executive developed entirely on her own time without using the Company’s equipment, supplies, facilities, or trade secret information except for those inventions that either:

·

Relate at the time of conception or reduction to practice of the invention to the Company’s business, or actual or demonstrably anticipated research or development of the Company; or

·

Result from any work performed by the Executive for the Company.

The text of California Labor Code Section 2870 is attached to this Agreement as Exhibit A.

c. Disclosure .  The Executive will promptly inform the Company of any Creations she conceives or develops during the Term.  The Executive shall (whether during her employment or after the termination of her employment) execute such written instruments and do other such acts as may be necessary in the opinion of the Company or its counsel to secure the Company’s rights in the Creations, including obtaining a patent, registering a copyright, or otherwise (and the Executive hereby irrevocably appoints the Company and any of its officers as her attorney in fact to undertake such acts in her name).  The Executive’s obligation to execute written instruments and otherwise assist the Company in securing its rights in the Creations will continue after the termination of her employment for any reason, the Company shall reimburse the Executive for any out-of-pocket expenses (but not attorneys’ fees) she incurs in connection with her compliance with this Section 9(c).

10. Arbitration .  

a. All disputes between Executive (and Executive’s attorneys, successors, and assigns) and the Company (and its affiliates, subsidiaries, shareholders, directors, officers, employees, agents, successors, attorneys, and assigns) relating in any manner to Executive’s employment or the termination of Executive’s employment, including, without limitation, all disputes arising under this Agreement (“ Arbitrable Claims ”), shall be resolved by final and binding arbitration to the fullest extent permitted by law.  Arbitrable Claims shall include, but are not limited to, contract (express or implied) and

13

 


 

tort claims of all kinds, as well as all claims based on any federal, state, or local law, statute, or regulation, excepting only claims under applicable workers’ compensation law and unemployment insurance claims.  By way of example and not in limitation of the foregoing, Arbitrable Claims shall include any claims arising under Title VII of the Civil Rights Act of 1964, the Age Discrimination in Employment Act, the Americans with Disabilities Act, the California Fair Employment and Housing Act, the Family Medical Leave Act as well as all claims under any applicable state or federal statute including but not limited to the California Labor Code, and any claims asserting wrongful termination, breach of contract, breach of the covenant of good faith and fair dealing, negligent or intentional infliction of emotional distress, harassment, discrimination, negligent or intentional misrepresentation, negligent or intentional interference with contract or prospective economic advantage, fraud, defamation, invasion of privacy, all claims related to disability and all wage or benefit claims, including but not limited to claims for salary, bonuses, profit participation, commissions, stock, stock options, vacation pay, fringe benefits or any form of compensation.  Arbitration shall be final and binding upon the Parties and shall be the exclusive remedy for all Arbitrable Claims, except that the Parties may seek interim injunctive relief and other provisional remedies in court as set forth in this Agreement.  The Parties hereby waive any rights they may have to trial by jury or any other form of administrative hearing or procedure in regard to the Arbitrable Claims.

b. Claims shall be arbitrated in accordance with the then-existing National Rules for the Resolution of Employment Disputes of the American Arbitration Association (“ AAA Employment Rules ”), as augmented by this Agreement.  Arbitration shall be initiated as provided by the AAA Employment Rules, although the written notice to the other Party initiating arbitration shall also include a statement of the claims asserted and all the facts upon which the claims are based.  Either Party may bring an action in court to compel arbitration under this Agreement and to enforce an arbitration award.  Otherwise, neither Party shall initiate or prosecute any lawsuit or administrative action in any way related to any Arbitrable Claim.  All arbitration hearings under this Agreement shall be conducted at the AAA office located nearest to San Diego, California.  The Federal Arbitration Act shall govern the interpretation and enforcement of this Section.

c. All disputes involving Arbitrable Claims shall be decided by a single arbitrator.  The arbitrator shall be selected by mutual agreement of the Parties within 30 days of the effective date of the notice initiating the arbitration.  If the Parties cannot agree on an arbitrator, then the complaining Party shall notify the AAA and request selection of an arbitrator in accordance with the AAA Employment Rules.  The arbitrator shall have only such authority to award equitable relief, damages, costs, and fees as a court would have for the particular claims asserted and any action of the arbitrator in contravention of this limitation may be the subject of court appeal by the aggrieved Party.  No other aspect of any ruling by the arbitrator shall be appealable, and all other aspects of the arbitrator’s ruling shall be final and non-appealable.  The arbitrator shall have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law.  The arbitrator shall be required to issue a written arbitration decision including the arbitrator’s essential findings, conclusions and a statement of award.  The Company shall pay all arbitration fees in excess of what the Executive would have to pay if the dispute were decided in a court of law.  The arbitrator shall have exclusive authority to resolve all Arbitrable Claims, including, but not limited to, whether any particular claim is arbitrable and whether all or any part of this Agreement is void or unenforceable.

d. Notwithstanding the foregoing, in order to provide for interim relief pending the finalization of arbitration proceedings hereunder, nothing in this Section 10 shall prohibit the parties from pursuing, a claim for interim injunctive relief, for other applicable provisional remedies, and/or for related attorneys’ fees in a court of competent jurisdiction in order to prevent irreparable harm pending the conclusion of the arbitration.

14

 


 

e. If for any reason all or part of this arbitration provision is held to be invalid, illegal, or unenforceable in any respect under any applicable law or regulation in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other part of this arbitration provision or any other jurisdiction, but this provision shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable part or parts of this arbitration provision had never been contained herein, consistent with the general intent of the Parties, as evidenced herein, insofar as possible.

11. Indemnification .  This Agreement incorporates, but does not supersede, Executive’s Indemnity Agreement with the Company, which survives the execution of this Agreement in all respects.

12. Integration .  This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior agreements between the parties concerning such subject matter, including, without limitation, the Prior Agreement, which shall terminate and have no further force or effect upon the effectiveness of this Agreement.

13. Successors .  This Agreement shall inure to the benefit of and be enforceable by the Executive’s personal representatives, executors, administrators, heirs, distributees, devisees and legatees.  In the event of the Executive’s death after her termination of employment but prior to the completion by the Company of all payments due her under this Agreement, the Company shall continue such payments to the Executive’s beneficiary designated in writing to the Company prior to her death (or to her estate, if the Executive fails to make such designation).  The Company shall require any successor to the Company to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place.

14. Enforceability .  If any portion or provision of this Agreement (including, without limitation, any portion or provision of any section of this Agreement) shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law.

15. Survival .  The provisions of this Agreement shall survive the termination of this Agreement and/or the termination of the Executive’s employment to the extent necessary to effectuate the terms contained herein.

16. Waiver .  No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving party.  The failure of any party to require the performance of any term or obligation of this Agreement, or the waiver by any party of any breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach.

17. Notices .  Any notices, requests, demands and other communications provided for by this Agreement shall be sufficient if in writing and delivered in person or sent by a nationally recognized overnight courier service or by registered or certified mail, postage prepaid, return receipt requested, to the Executive at the last address the Executive has filed in writing with the Company or, in the case of the Company, at its main offices, attention of the Board.

18. Amendment .  This Agreement may be amended or modified only by a written instrument signed by the Executive and by a duly authorized representative of the Company.

15

 


 

19. Governing Law .  This is a California contract and shall be construed under and be governed in all respects by the laws of California for contracts to be performed in that State and without giving effect to the conflict of laws principles of California or any other State.  In the event of any alleged breach or threatened breach of this Agreement, the Executive hereby consents and submits to jurisdiction in the State of California.

20. Counterparts .  This Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be taken to be an original; but such counterparts shall together constitute one and the same document.



[SIGNATURE PAGE FOLLOWS]

 

16

 


 

 

IN WITNESS WHEREOF, the parties have executed this Agreement effective on the date and year first above written.

PriceSmart, Inc.





By:  /s/ Francisco Velasco
Name:  Francisco Velasco

Title:  Executive Vice President, General Counsel 







/s/ Sherry S. Bahrambeygui

Sherry S. Bahrambeygui

17

 


 

Exhibit A

California Labor Code Section 2870



Any provision in an employment agreement which provides that an employee shall assign or offer to assign any of his or her rights in an invention to his or her Company shall not apply to an invention that the employee developed entirely on his or her own time without using the Company’s equipment, supplies, facilities, or trade secret information except for those inventions that either:



a) relate at the time of conception or reduction to practice of the invention to the Company’s business or actual or demonstrably anticipated research or development of the Company, or



b) result from any work performed by the employee for the Company.







18